Molecular imaging and theranostics

Host: Wim Oyen, Institute of Cancer Research, UK

11:00-12:30

Room: Default Location

The session will address molecular imaging (MI) approaches for diagnosis and targeted systemic radiotherapy at various stages of clinical development.

The session will include presentations on:
– Non-isotope based MI (optica, photoacoustic, hyperpolarized MR)
– PSMA targeting in prostate cancer patients using PSMA-binding radiolabeled molecules
– The evidence-based role of FDG-PET/CT for staging, risk-stratification and early monitoring of response in patients with malignant lymphoma

Confirmed speakers:
Sally Barrington, King’s College London
Sarah Bohndiek, Cancer Research UK Cambridge Institute
Matthias Eiber, Technische Universität München